Compression of the Lid Margin Increase Microbial Contamination Risk of Patients Undergoing Cataract Surgery
1 other identifier
interventional
306
1 country
1
Brief Summary
To investigate whether compression of the lid margin increase microbial contamination risk of patients undergoing cataract surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 20, 2013
CompletedFirst Posted
Study publicly available on registry
May 22, 2013
CompletedMay 22, 2013
May 1, 2013
6 months
May 20, 2013
May 20, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
positive rate of culture
5months
Secondary Outcomes (1)
bacteria distribution of the culture
5months
Study Arms (2)
compression
EXPERIMENTALcompression and scrub of lid margin for 5 circles before cataract surgery
control
ACTIVE COMPARATORno compression or scrub of lid margin
Interventions
compression and scrub of lid margin for 5 circles before cataract surgery
Eligibility Criteria
You may qualify if:
- (1) Age \> 60 years; (2) clinical diagnosis of age related cataract, without previous recent ocular surgery; (3) undergoing phacoemulsification with implantation of intraocular lens ; (4) able to give informed consent.
You may not qualify if:
- (1) any inflammation of the eye or other parts of the body within the previous 3 months; (2) chronic use of any types ophthalmic medication; (3) contact lens wear; (4) ocular surgery within the past 3 months; (5) use of systemic antibiotics within 30 days; (6) use of eyedrops in either eye within 3 days of enrollment; (7) need for concurrent glaucoma, cornea or other surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Orbislead
- Sun Yat-sen Universitycollaborator
Study Sites (1)
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510080, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Zhongshan Ophthalmic Center
Study Record Dates
First Submitted
May 20, 2013
First Posted
May 22, 2013
Study Start
October 1, 2011
Primary Completion
April 1, 2012
Study Completion
July 1, 2012
Last Updated
May 22, 2013
Record last verified: 2013-05